Velan Capital Investment Management LP → Jasper Therapeutics, Inc. JSPR

Stake: — Shares: — Class: Voting Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 16.30

6,218,239 shares short · +7.1% vs prior

Other 13D/G Filings on Jasper Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-20	SCHEDULE 13D/A	Velan Capital Investment Management LP	—	3,021,915	view →

Other Filings by Velan Capital Investment Management LP

Filed	Form	Issuer	Stake	Shares
2026-08-25	SCHEDULE 13D/A	Edesa Biotech, Inc.	—	1,081,385	view →
2026-07-20	SCHEDULE 13D/A	Jasper Therapeutics, Inc.	—	3,021,915	view →
2024-05-16	SC	ALIMERA SCIENCES INC	—	—	view →
2022-07-12	SC	Radius Health, Inc.	—	—	view →
2022-05-25	SC	Radius Health, Inc.	—	—	view →
2022-03-15	SC	Radius Health, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →